Rephine is our GMP and regulatory
partner for this plant, as well as for future
businesses in initial phases
Client Testimonial
About this Case Study
For a young biotech company with just six employees, launching a new automated manufacturing plant was an exciting step forward. It was also a major regulatory challenge. With limited internal GMP experience, the company needed to achieve EU GMP compliance without slowing daily operations or delaying authorisation.
Rephine supported the client from early facility design through to qualification and validation, designing a practical Quality Management System suited to a small, highly automated organisation. The focus was on embedding GMP requirements into everyday operations in a way that felt manageable and sustainable for a lean team.
By combining technical expertise with close collaboration and knowledge transfer, Rephine helped the client move confidently from start up to authorised manufacturer.
Key outcomes included:
- EU GMP authorisation for the new manufacturing facility
- A right sized QMS aligned to the realities of a small organisation
- Successful audit outcomes and improved regulatory confidence
- Increased business credibility and growth opportunities
- GMP knowledge embedded across operational teams
✅ Download the full case study to discover:
- How small biotech companies can achieve GMP compliance with limited resources
- How early GMP input supports smoother facility qualification and validation
- How practical consultancy accelerates readiness without over complexity
Result: A compliant, authorised manufacturing operation supported by a scalable QMS and a trusted GMP partner.
Download the Case Study
View our other resources and company news
- White Paper
Is your quality dashboard testing anything, or just showing green? A practical guide to KPIs and dashboards that surface risk early enough to act on...
- Case Study
A mid-sized pharmaceutical company embarked on a three-year digital transformation to validate TrackWise Digital across three sequential phases. See how full operational support within ValGenesis...
- Article
As regulatory demands grow, even strong QA teams reach their limits. Here is how flexible QA support helps pharmaceutical companies manage change, reduce risk and...
- Article
Rephine Barcelona S.L. is now accredited to ISO/IEC 17020 as an inspection body for specific GMP and GDP audit activities. We explain what the accreditation...
- White Paper
Relying on historical cleaning limits or visual cleanliness checks to justify shared manufacturing carries more regulatory risk than many sites realise. Find out what a...
- Article
Every change to a validated system carries risk. Discover the core components, roles and best practices that keep Change Management in CSV projects controlled, compliant...
- Case Study
A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full...
- White Paper
Turn data integrity findings into a sustainable, risk based remediation plan. A practical 7 phase framework for pharma labs....
- Article
Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide...
